World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
28001
World Ranking
17881
National Ranking
8920

Overview

James R. Stone is affiliated with Harvard University in the United States. Their research primarily focuses on medicine, with significant contributions in cardiology and cardiovascular medicine, infectious diseases, epidemiology, pulmonary and respiratory medicine, and neurology.

The scientist's recent publications cover a range of topics related to COVID-19 and cardiovascular pathology. Notable papers include:

  • COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets (2021, Nature)
  • Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study (2020, European Heart Journal)
  • Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis (2020, European Heart Journal)
  • Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection (2020, Nature Communications)
  • Deep learning enables genetic analysis of the human thoracic aorta (2021, Nature Genetics)

Their research work encompasses a variety of topics, mainly related to viral infections, immune responses, and cardiovascular implications. These topics include:

  • COVID-19 Clinical Research Studies
  • Traumatic Brain Injury Research
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Viral Infections and Immunology Research
  • IgG4-Related and Inflammatory Diseases

The scientist frequently collaborates with colleagues including Dejan Juric, Mari Mino-Kenudson, Christopher J. Pinto, Pritha Sen, and Daniel A. Zlotoff.

James R. Stone has published multiple articles in various scientific journals. Frequent publication venues include:

  • New England Journal of Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cardiovascular Pathology
  • Circulation
  • European Heart Journal

Best Publications

  • Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters

    Andrea Ventura;Amanda G. Young;Monte M. Winslow;Laura Lintault

  • Hydrogen peroxide: a signaling messenger.

    James R. Stone;Suping Yang

  • Myocardial infarction accelerates atherosclerosis

    Partha Dutta;Gabriel Courties;Ying Wei;Florian Leuschner;Florian Leuschner

  • EGFR Mutations and ALK Rearrangements Are Associated With Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis

    Justin F. Gainor;Alice T. Shaw;Lecia V. Sequist;Xiujun Fu

  • Large-scale evaluation of ANTs and FreeSurfer cortical thickness measurements.

    Nicholas J. Tustison;Philip A. Cook;Arno Klein;Gang Song

  • COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.

    Toni M. Delorey;Carly G. K. Ziegler;Graham Heimberg;Rachelly Normand

  • Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations

    John H. Stone;Arezou Khosroshahi;Vikram Deshpande;John K. C. Chan

  • Activated Interstitial Myofibroblasts Express Catabolic Enzymes and Mediate Matrix Remodeling in Myxomatous Heart Valves

    Elena Rabkin;Masanori Aikawa;James R. Stone;Yoshihiro Fukumoto

  • The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.

    Zachary S Wallace;Ray P Naden;Suresh Chari;Hyon Choi

  • 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology

    Ornella Leone;John P. Veinot;Annalisa Angelini;Ulrik T. Baandrup

  • Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.

    Lipika Goyal;Supriya K. Saha;Leah Y. Liu;Giulia Siravegna

  • All in the family: the BTB/POZ, KRAB, and SCAN domains.

    Tucker Collins;James R. Stone;Amy J. Williams

  • Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease

    Hamid Mattoo;Vinay S. Mahajan;Takashi Maehara;Vikram Deshpande

  • Acquired Resistance to Crizotinib from a Mutation in CD74–ROS1

    Mark M. Awad;Ryohei Katayama;Michele McTigue;Wei Liu

  • Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study

    Cristina Basso;Ornella Leone;Stefania Rizzo;Monica De Gaspari

  • Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.

    S. Unizony;L. Arias-Urdaneta;E. Miloslavsky;S. Arvikar

  • Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases.

    James R. Stone;Patrick Bruneval;Annalisa Angelini;Giovanni Bartoloni

  • A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias

    D. J. Deangelo;R. M. Stone;L. B. Silverman;W. Stock

  • Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease

    James R Stone

  • Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association For European Cardiovascular Pathology: II. Noninflammatory degenerative diseases - nomenclature and diagnostic criteria.

    Marc K. Halushka;Annalisa Angelini;Giovanni Bartoloni;Cristina Basso

Frequent Co-Authors

John H. Stone
John H. Stone Harvard University
Brian B. Avants
Brian B. Avants University of Virginia
Vikram Deshpande
Vikram Deshpande Harvard University
Elisabeth A. Wilde
Elisabeth A. Wilde Baylor College of Medicine
Peter A. Merkel
Peter A. Merkel University of Pennsylvania
David C. Seldin
David C. Seldin Boston University
Mari Mino-Kenudson
Mari Mino-Kenudson Harvard University
Gary S. Hoffman
Gary S. Hoffman Cleveland Clinic
Nir Hacohen
Nir Hacohen Harvard University
Philip A. Cook
Philip A. Cook University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring alternatives to a traditional USA medical degree, there are several online pathways that offer rewarding careers in healthcare. Many students consider easy nursing programs to get into, which often have accessible admission requirements and can fast-track you into nursing roles.

For those who want to enter healthcare without patient care duties, medical billing and coding schools that accept fafsa are a great option. These programs provide skills for in-demand administrative jobs and may offer financial aid opportunities.

Some nursing schools no longer require admissions tests like TEAS or HESI, making the process more accessible for diverse applicants. Learn more from do you have to take the teas test to get into nursing school.

Additionally, leadership-minded students can consider a health care administration degree. These accelerated online programs prepare graduates for management roles within the healthcare industry, often in less time than traditional degrees.

Best Scientists Citing James R. Stone

Trending Scientists

Recently Published Articles